View in EDS

48-hour Induction of Transdermal Buprenorphine to Extended-release Buprenorphine.

Saved in:
Bibliographic Details
Title: 48-hour Induction of Transdermal Buprenorphine to Extended-release Buprenorphine.
Authors: Azar P; From the Integrated Psychiatry, Pain, and Addiction Service, Vancouver General Hospital, Vancouver, British Columbia, Canada (PA, JSHW, NM, MJI); Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada (PA, NM); Addictions and Concurrent Disorders Research Group, Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada (JSHW, RMK); BC Mental Health & Substance Use Services, Provincial Health Services Authority, British Columbia, Canada (NM); Substance Use Response and Facilitation Service, BC Children's Hospital, Provincial Health Services Authority, British Columbia, Canada (MJI); Pharmaceutical Sciences, Vancouver General Hospital, Vancouver, British Columbia, Canada (NP); Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada (NP); British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada (AA, MH, RB, JSGM); Pharmacokinetics Modeling and Simulation Laboratory, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada (ST, ARM); Department of Family Practice, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada (MH); School of Population and Public Health, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada (RB); and Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada (JSGM)., Wong JSH, Mathew N, Ignaszewski MJ, Partovi N, Krausz RM, Ajidahun A, Thotakura S, Harris M, Barrios R, Montaner JSG, Maharaj AR
Source: Journal of addiction medicine [J Addict Med] 2024 Jan-Feb 01; Vol. 18 (1), pp. 82-85. Date of Electronic Publication: 2023 Oct 17.
Publication Type: Case Reports; Journal Article
Journal Info: Publisher: Wolters Kluwer Health, Inc Country of Publication: Netherlands NLM ID: 101306759 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1935-3227 (Electronic) Linking ISSN: 19320620 NLM ISO Abbreviation: J Addict Med Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37847573
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: 48-hour Induction of Transdermal Buprenorphine to Extended-release Buprenorphine.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Azar+P%22">Azar P</searchLink>; From the Integrated Psychiatry, Pain, and Addiction Service, Vancouver General Hospital, Vancouver, British Columbia, Canada (PA, JSHW, NM, MJI); Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada (PA, NM); Addictions and Concurrent Disorders Research Group, Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada (JSHW, RMK); BC Mental Health & Substance Use Services, Provincial Health Services Authority, British Columbia, Canada (NM); Substance Use Response and Facilitation Service, BC Children's Hospital, Provincial Health Services Authority, British Columbia, Canada (MJI); Pharmaceutical Sciences, Vancouver General Hospital, Vancouver, British Columbia, Canada (NP); Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada (NP); British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada (AA, MH, RB, JSGM); Pharmacokinetics Modeling and Simulation Laboratory, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada (ST, ARM); Department of Family Practice, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada (MH); School of Population and Public Health, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada (RB); and Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada (JSGM).<br /><searchLink fieldCode="AU" term="%22Wong+JSH%22">Wong JSH</searchLink><br /><searchLink fieldCode="AU" term="%22Mathew+N%22">Mathew N</searchLink><br /><searchLink fieldCode="AU" term="%22Ignaszewski+MJ%22">Ignaszewski MJ</searchLink><br /><searchLink fieldCode="AU" term="%22Partovi+N%22">Partovi N</searchLink><br /><searchLink fieldCode="AU" term="%22Krausz+RM%22">Krausz RM</searchLink><br /><searchLink fieldCode="AU" term="%22Ajidahun+A%22">Ajidahun A</searchLink><br /><searchLink fieldCode="AU" term="%22Thotakura+S%22">Thotakura S</searchLink><br /><searchLink fieldCode="AU" term="%22Harris+M%22">Harris M</searchLink><br /><searchLink fieldCode="AU" term="%22Barrios+R%22">Barrios R</searchLink><br /><searchLink fieldCode="AU" term="%22Montaner+JSG%22">Montaner JSG</searchLink><br /><searchLink fieldCode="AU" term="%22Maharaj+AR%22">Maharaj AR</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101306759%22">Journal of addiction medicine</searchLink> [J Addict Med] 2024 Jan-Feb 01; Vol. 18 (1), pp. 82-85. <i>Date of Electronic Publication: </i>2023 Oct 17.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Case Reports; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wolters+Kluwer+Health%2C+Inc%22">Wolters Kluwer Health, Inc </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>101306759 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1935-3227 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219320620%22">19320620 </searchLink><i>NLM ISO Abbreviation: </i>J Addict Med <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37847573
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1097/ADM.0000000000001231
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 82
    Titles:
      – TitleFull: 48-hour Induction of Transdermal Buprenorphine to Extended-release Buprenorphine.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Azar P
      – PersonEntity:
          Name:
            NameFull: Wong JSH
      – PersonEntity:
          Name:
            NameFull: Mathew N
      – PersonEntity:
          Name:
            NameFull: Ignaszewski MJ
      – PersonEntity:
          Name:
            NameFull: Partovi N
      – PersonEntity:
          Name:
            NameFull: Krausz RM
      – PersonEntity:
          Name:
            NameFull: Ajidahun A
      – PersonEntity:
          Name:
            NameFull: Thotakura S
      – PersonEntity:
          Name:
            NameFull: Harris M
      – PersonEntity:
          Name:
            NameFull: Barrios R
      – PersonEntity:
          Name:
            NameFull: Montaner JSG
      – PersonEntity:
          Name:
            NameFull: Maharaj AR
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2024 Jan-Feb 01
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1935-3227
          Numbering:
            – Type: volume
              Value: 18
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Journal of addiction medicine
              Type: main
ResultId 1